PMVP Stock Analysis: Buy, Sell, or Hold?
PMVP - PMV Pharmaceuticals, Inc
$1.06
-0.02 (-1.85%)
▼
5d:
-9.4%
30d:
-15.2%
90d:
-24.29%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 02, 2026
26d
Get Alerted When PMVP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PMVP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PMVP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PMVP is currently trading at $1.06, which is considered oversold relative to its 30-day fair value range of $1.11 to $1.23.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is currently testing key support at $1.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMVP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.60 (+617.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is currently testing key support at $1.05. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMVP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.60 (+617.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.11 -
$1.23
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 617.0% below Wall St target ($7.60)
- CAUTION: 5-day price weakness (-9.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.11 -
$1.23
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.05
Resistance Level
$1.25
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.74
Wall Street Target
$7.60
(+617.0%)
Last updated: February 02, 2026 6:15 PM ET
Data refreshes hourly during market hours. Next update: 7:15 PM
Data refreshes hourly during market hours. Next update: 7:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMVP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Orbimed Advisors Llc
SELL
500000 shares
2025-09-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 64 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
